Drug intelligence / Profile preview

15(R)-methyl-prostaglandin D2

Development stage
Unknown
Modality
Small Molecules
01

Overview

15(R)-methyl-prostaglandin D2 is a synthetic small-molecule analog of prostaglandin D2 (PGD2) that acts as a potent and selective agonist of the CRTH2 (chemoattractant receptor-homologous molecule expressed on Th2 cells) receptor, also known as the DP2 receptor. It exhibits approximately 5-fold greater potency than native PGD2 and significantly higher selectivity for DP2 over the DP1 receptor. Due to its resistance to metabolic degradation and high specificity, it is primarily utilized as a pharmacological research tool to investigate the role of DP2 receptor activation in inflammatory and allergic conditions, such as asthma, atopic dermatitis, and urticaria. Research has demonstrated its ability to induce cytokine secretion, such as eotaxin-3 and TSLP, in human keratinocytes and other immune cells.

Other names
15(R)-methyl-prostaglandin D215(R)-15-methylprostaglandin D2
02

Targets

PTGDR (Prostanoid DP1 receptor)PTGDR2 (Prostaglandin D2 receptor 2)

Beyond the preview

Go deeper on 15(R)-methyl-prostaglandin D2.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on 15(R)-methyl-prostaglandin D2.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call